When Parkinson is Not Parkinson – Diagnostic and Management Challenges of Essential Tremor: Case Series from the Movement Disorders Center.
DOI:
https://doi.org/10.52692/1857-0011.2025.3-83.17Keywords:
essential tremor, Parkinson’s disease, propranolol, movement disordersAbstract
Introduction: Tremor (Tr), a rhythmic and involuntary movement characteristic of disorders such as essential tremor (ET) and Parkinson’s disease (PD), can be a source of confusion for general neurologists.
The aim of this study was to identify the difficulties associated with the diagnosis and management of ET in the Republic of Moldova, based on the experience of the Movement Disorders Center.
Materials and Methods: A retrospective analysis of 14 clinical cases with ET/ET-plus evaluated at the Movement Disorders Center of the “D. Gherman” Institute of Neurology and Neurosurgery (2024–2025) was conducted. Demographic, clinical, and therapeutic data were collected, and descriptive statistical analysis was performed using SPSS v.23.
Results: Among 87 patients suspected of PD, 14 were confirmed with ET (simple ET 3 [21.4%], ET-plus 9 [64.3%], PD + ET 2 [14.3%]), with a median age at presentation of 73 years and tremor onset at 66 years. All patients exhibited kinetic and postural tremor of the upper limbs, with involvement of the head (57.1%), chin (7.1%), and voice (7.1%). Associated motor symptoms included ataxia (42.9%) and parkinsonism (21.4%). Most patients (57.1%) had prior treatments with partial or no effect; propranolol 60 mg/day was initiated in 78.6% of cases.
Conclusions: Diagnosis and management of tremor remain challenging due to the overlap of ET and PD symptoms, limited access to functional investigations, essential medications, and the lack of surgical options. The results highlight the need for standardized protocols and continuous training of neurologists to optimize long-term management.
References
Bhatia KP, Bain P, Bajaj N, Elble RJ, Hallett M, Louis ED, et al. Consensus Statement on the classification of tremors from the task force on tremor of the International Parkinson and Movement Disorder Society. Mov Disord. 2018;33:75–87.
Lenka A, Jankovic J. Tremor Syndromes: An Updated Review. Front Neurol. 2021;12:1–17.
Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30:1591–601.
Sepúlveda Soto MC, Fasano A. Essential tremor: New advances. Clin Park Relat Disord. 2020;3:100031.
Lolekha P, Dharmasaroja P, Uransilp N, Sukphulloprat P. The differences in clinical characteristics and natural history between essential tremor and essential tremor plus. Sci Rep. 2022;1–7.
Song P, Zhang Y, Zha M, Yang Q, Ye X, Yi Q, et al. The global prevalence of essential tremor , with emphasis on age and sex : A meta-analysis. J Glob Health. 2021;11:1–8.
Angelini L, Paparella G, De Biase A, Maraone A, Panfili M, et al. Longitudinal study of clinical and neurophysiological features in essential tremor. Eur J Neurol. 2023;30:631–40.
Postuma RB, Berg D, Stern M, Poewe W, Marek K, Litvan I. MDS Clinical Diagnostic Criteria for Parkinson’ s Disease. Mouv Disord. 2015;30.
Gavriliuc O, Fala P, Gavriliuc M, Andrușca A. Tremorul Esențial - Criterii de Diagnostic și Modalități de Tratament. Bul Acad Stiint a Mold. 2021;25–9.
Haubenberger D, Hallet M. Essential tremor. N Engl J Med. 2018;378:1802–10.
Kosmowska B, Jadwiga W. The Pathophysiology and Treatment of Essential Tremor : The Role of Adenosine and Dopamine Receptors in Animal Models. Biomolecules. 2021;
Dirkx MF, Bologna M. The pathophysiology of Parkinson’s disease tremor. J Neurol Sci. 2022;435:120196.
Zhang M, Li W, Hu L, Chen L, Yang L, Zhang T, et al. Oral propranolol for treatment of the subgroups of essential tremor : a systematic review and meta- analysis protocol. BMJ Open. 2020;1–5.
Pal PK. Guidelines for management of essential tremor. Ann Indian Acad Neurol. 2011;14:25–8.
Ferreira JJ, Mestre TA, Lyons KE, Benito-león J. MDS Evidence-Based Review of Treatments for Essential Tremor. Mouv Disord. 2019;34:950–8.
Ghanekar S, Zesiewicz T. Treatment of Essential Tremor. Pract Neurol. 2023;20–3.
Knox C, Wilson M, Klinger CM, Mark F, Oler E, Wilson A, et al. DrugBank 6.0: the DrugBank Knowledge base for 2024. Nucleic Acids Res. 2024;52:1265–75.
Spindler, Meredith A. TD. Pharmacologic treatment of parkinson disease. UpToDate. 2021;
Bega D, Kuo PH, Chalkidou A, Grzeda MT, et al. Clinical utility of DaTscan in patients with suspected Parkinsonian syndrome: a systematic review and meta- analysis. npj Park Dis. 2021;7.
Downloads
Published
License
Copyright (c) 2026 Bulletin of the Academy of Sciences of Moldova. Medical Sciences

This work is licensed under a Creative Commons Attribution 4.0 International License.
